Effectiveness and cardiovascular safety of delamanid-containing regimens in adults with multidrug-resistant or extensively drug-resistant tuberculosis: A nationwide cohort study from Belarus, 2016-18

Effectiveness and cardiovascular safety of delamanid-containing regimens in adults with multidrug-resistant or extensively drug-resistant tuberculosis: A nationwide cohort study from Belarus, 2016-18

To address the sub-optimal treatment outcomes among patients with multidrug-resistant (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB), the National TB Programme in Belarus started using new drugs such as bedaquiline and delamanid in 2015-16. In this study, we assessed cardiovascular s...

Full description

Bibliographic Details
Main Authors: Vera Auchynka, Ajay M.V. Kumar, Hennadz Hurevich, Yuliia Sereda, Varvara Solodovnikova, Dzmitry Katovich, Svetlana Setkina, Askar Yedilbayev, Aliaksandr Skrahin, Alena Skrahina
Format: Article
Language:English
Published: PAGEPress Publications 2021-01-01
Series:Monaldi Archives for Chest Disease
Subjects:
new anti-tuberculosis drugs
fluoroquinolone resistance
rifampicin resistance
second-line injectable drug resistance
adverse drug safety monitoring
Online Access:https://monaldi-archives.org/index.php/macd/article/view/1647

Internet

https://monaldi-archives.org/index.php/macd/article/view/1647

Similar Items